Skip to main content
. 2021 Oct 14;29(1):1–14. doi: 10.1530/ERC-21-0152

Table 1.

Patient characteristics.

Characteristic Subgroup Total NEN (n = 181, %) NEC (n = 152, %) NETG3 (n = 29, %)
Age
<50 13 (7) 9 (5.9) 4 (13.8)
50–59 20 (11.6) 18 (11.8) 2 (6.9)
60–69 64 (35.4) 55 (36.2) 9 (31)
70+ 84 (46.4) 70 (46.1) 14 (48.3)
Sex
Male 109 (60.2) 94 (61.8) 15 (51.7)
Female 72 (39.8) 58 (38.2) 14 (48.3)
Site
Right colon 38 (21) 36 (23.7) 2 (6.9)
Rectum 37 (20.4) 36 (23.7) 1 (3.4)
Esophagus 19 (10.5) 18 (11.8) 1 (3.4)
Gastric 17 (9.4) 16 (10.5) 1 (3.4)
Unknown 25 (13.8) 19 (12.5) 6 (20.7)
Pancreas 25 (13.8) 13 (8.6) 12 (41.4)
Left colon 10 (5.5) 9 (5.9) 1 (3.4)
Gallbladder/duct 3 (1.7) 3 (2) 0 (0.0)
Other 3 (1.7) 2 (1.3) 1 (3.4)
Small bowel 4 (2.2) 0 (0.0) 4 (13.8)
Cell type
Large cell 87 (57.2)
Small cell 65 (42.8)
Ki-67
21–55% 36 (19.9) 13 (8.6) 23 (79.3)
>55% 132 (72.9) 130 (85.5) 2 (6.9)
>20% (exact value not specified) 13 (7.2) 9 (5.9) 4 (13.8)
Surgery of primary tumour
Resected (prior to sampling) 59 (32.6) 50 (32.9) 9 (31)
Not resected 122 (67.4) 102 (67.1) 20 (69)
Disease
Non-metastatic (stage I–III) 36 (19.9) 31 (20.4) 5 (17.2)
Metastatic (stage IV) 145 (80.1) 121 (79.6) 24 (82.8)
Smoking habit
Smoker 37 (20.4) 33 (21.7) 4 (13.8)
Ex-smoker 54 (29.8) 45 (29.6) 9 (31)
Non-smoker 73 (40.3) 60 (39.5) 13 (44.8)
Unknown 17 (9.4) 14 (9.2) 3 (10.3)